<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<meta charset="utf-8">
<title>ISTOP LAW</title>
<style>
img{border:0;}
table.cont ul li{color:#004fc8; }
table.cont ul li span{color: #000000;}
p{ margin:0 !important; padding:0 !important;}
a:-webkit-any-link {
	text-decoration: none;
}
.ii a[href] {
	color:#000001 !important;
}
</style>
</head>
<body style="font-family: Arial, Helvetica; margin:0; background-color:#adb7c7;">

<table width="100%" border="0" cellpadding="2" cellspacing="0" bgcolor="#CCCCCC">
  <tr>
    <td><strong>From:&nbsp;</strong>Purdue Pharma L.P.</td>
  </tr>
  <tr>
    <td><strong>Sent:&nbsp;</strong>Monday, June 30, 2014</td>
  </tr>
  <tr>
    <td><strong>To:&nbsp;</strong>Healthcare Professional</td>
  </tr>
  <tr>
    <td><strong>Subject Alt 1:&nbsp;</strong>Information on Amendments to Title 10 NYCRR  Part 80 Rules and Regulations on Controlled Substances</td>
  </tr>
</table>
<custom name="opencounter" type="tracking">
<table width="600" border="0" align="center" cellpadding="0" cellspacing="0" bgcolor="#ffffff">
          <tr>
            <td>
<table width="100%" border="0" align="center" bgcolor="#adb7c7" cellpadding="0" cellspacing="0">
  <tr>
    <td colspan="4" width="100%" style="font-size:10px; padding:10px 0; text-align:center; color:#000000;">
		<a href="file:///Macintosh HD/Users/jasonsanchez/Desktop/jobs/OXYCONTIN/A8877-SCS-E/originals/A8877-SCS-E/%%view_email_url%%" style="font-family:Arial;font-size:10px; color:#000000; text-decoration:none!important;border-bottom:none;"><span style="color:#000000;">View as Web Page</span></a>&nbsp;|&nbsp;<a href="https://www.purduehcp.com/hcpportal/f?p=201202:REG:0::::c,s,utm_source,utm_medium,utm_content,utm_campaign,P1000_FIRST_NAME,P1000_LAST_NAME,P1000_NPI_NUMBER,P1000_EMail,P1000_ZIP_CODE:exp_scripts,savings,oxy_email,email,request_savings_header,exp_scripts,%%=PROPERCASE(First_Name)=%%,%%=PROPERCASE(Last_Name)=%%,%%NPI_NUMBER%%,%%EMAIL ADDRESS%%,%%ZIPCODE%%" style="font-family:Arial;font-size:10px; color:#000000; text-decoration:none!important;border-bottom:none;"><span style="color:#000000;">Request Savings Cards</span></a>&nbsp;|&nbsp;<a href="https://www.purduehcp.com/hcpportal/f?p=201201:REQREP:0::::c,utm_source,utm_medium,utm_content,utm_campaign:exp_scripts,oxy_email,email,request_rep_header,exp_scripts" style="font-family:Arial;font-size:10px; color:#cdcdcd; text-decoration:none!important;border-bottom:none;"><span style="color:#000000;">Request a Rep</span></a>&nbsp;|&nbsp;<a href="https://www.purduehcp.com/hcpportal/f?p=201201:CONTACT:0::::c,utm_source,utm_medium,utm_content,utm_campaign:exp_scripts,oxy_email,email,contact_us_header,exp_scripts" style="font-family:Arial;font-size:10px; color:#cdcdcd; text-decoration:none!important;border-bottom:none;"><span style="color:#000000;">Contact Us</span></a>
     </td>
  </tr>
  <tr>
  <td colspan="4" align="center" valign="top" bgcolor="#FFFFFF">
					  <table width="100%" border="0" cellspacing="0" cellpadding="0">
						  <tr>
  <td align="center" valign="top" bgcolor="#FFFFFF">
					  <table border="0" cellspacing="0" cellpadding="0">
						  <tr>
							  <td align="center" valign="top" style="padding-top:10px; padding-bottom:3px; padding-left: 0px; padding-right:0px; 
																		border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1px">
								  <div style="font-family:Arial, Helvetica, sans-serif; font-size:12px; line-height:16px; color:#000000; font-weight:bold;">
									  <a href="https://www.purduehcp.com/pages/report-adverse-events.aspx?cid=email_2011rtty" style="color:#000000; text-decoration:none"><span style="color:#000000; text-decoration:none">Report Adverse Reactions</span></a>&nbsp; | &nbsp;
										
									  <a href="#isi" style="color:#000000; text-decoration:none"><span style="color:#000000; text-decoration:none">Important Safety Information</span></a>&nbsp; | &nbsp;
									  <a href="http://www.purduepharma.com/pressroom/news/OxycontinPI.pdf?cid=email_2011rtty" style="color:#000000; text-decoration:none"><span style="color:#000000; text-decoration:none">Full Prescribing Information</span></a>
								  </div>
							  </td>
						  </tr>
					  </table>
				   </td>
				</tr>
					  </table>
				   </td>
				</tr>
                <tr>
				  <td colspan="4" align="center" valign="top" bgcolor="#FFFFFF" style="padding-top:15px; padding-bottom:15px">
					  <div style="font-family:Arial, Helvetica, sans-serif; font-size:12px; line-height:16px; color:#888888; font-weight:bold; font-style:italic">
						  Please do not reply to this e-mail. There are links below for contacting Purdue Pharma L.P. 
					  </div>
				  </td>
			  </tr>
                <tr>
				<td bgcolor="#FFFFFF" width="10px">&nbsp;</td>
				<td width="150" bgcolor="#FFFFFF" valign="top"><a href="http://www.purduepharma.com?utm_source=oxy_email&utm_medium=email&utm_content=purdue_logo_footer&utm_campaign=exp_scripts"><img src="images/footer_logos-2-201404.png" width="100" height="49" alt="Purdue Logo" style="border:none;display:block;"></a></td>
				  <td valign="top" align="right" bgcolor="#FFFFFF" style="padding-bottom:10px;">
					  <a href="https://www.purduehcp.com/hcpportal/f?p=201202:REG:0::::c,s,utm_source,utm_medium,utm_content,utm_campaign,P1000_FIRST_NAME,P1000_LAST_NAME,P1000_NPI_NUMBER,P1000_EMail,P1000_ZIP_CODE:exp_scripts,default,oxy_email,email,oxy_logo_footer,exp_scripts,%%=PROPERCASE(First_Name)=%%,%%=PROPERCASE(Last_Name)=%%,%%NPI_NUMBER%%,%%EMAIL ADDRESS%%,%%ZIPCODE%%"><img src="images/oxy_header.png" width="300" height="80" alt="Purdue Pharma L.P., One Stamford Forum, Stamford CT 06901-3431" style="display:block; border:none"></a>
				  </td>
</table></td></tr></table>
        <table width="600" border="0" align="center" cellpadding="0" cellspacing="0" bgcolor="#ffffff">
          <tr>
            <td><table width="100%" border="0" cellpadding="0" cellspacing="0">
              <tr>
                <td valign="top"><table width="281" border="0" cellpadding="0" cellspacing="0">
                  
                   
                  <tr>
                    <td align="left">
                         <table width="100%" border="0" cellspacing="0" cellpadding="0">
                                
                                  <tr>
                                    <td width="6%">&nbsp;</td>
                                    <td width="94%" colspan="2" align="left" valign="top">
										<table border="0" cellpadding="0" cellspacing="0">
											<tr>
												<td valign="top">
													
													<table cellpadding="0" cellspacing="0" border="0">
														<tr><td width="301">
															<table width="100%" cellpadding="0" cellspacing="0" border="0">
															 <tr>
															   <td valign="top" style="padding-bottom:8px; padding-top:8px; font-family: Arial, Helvetica;font-size:12px;line-height: 16px;"><p>Dear Healthcare Professional:</p><br> 
														       <p>As you may already know, effective <strong>March 27, 2015</strong>, it will be mandatory for practitioners in New York State to issue electronic prescriptions for controlled and non-controlled substances.</p>
															   </td>
															   </tr>
															   
															   <tr>
															   <td valign="top" style="padding-bottom:8px; font-family: Arial, Helvetica;font-size:12px;line-height: 16px;">
<p><strong>An electronic prescription will be necessary to allow a pharmacist to accept, annotate, dispense and electronically archive OxyContin<sup style="line-height:0px;">&reg;</sup> (oxycodone HCI extended-release tablets CII) and other controlled substances prescriptions.</strong></p>
</td>
</tr>
<tr>
<td valign="top" style="padding-bottom:8px; font-family: Arial, Helvetica;font-size:12px;line-height: 16px;">


<p>It is currently permissible in New York State to electronically prescribe controlled substances (EPCS) in Schedules II through V and non-controlled substances, but a <em>practitioner is required to use an electronic prescribing computer application that meets all federal requirements</em>.</p>

<p></p></span></td></tr>
															</table></td></tr>
													</table><table width="100%" border="0" cellspacing="0" cellpadding="0">
                          
                          
                  
                  
                          
                            
						</table>
												</td>
												
										  </tr>
											</table>
                                    </td>
                                  </tr>                                   
                         </table>

                    </td>
                  </tr>
             
				  
                  
				  				  
				  <tr>
					 <td style="padding:0 0 0 19px; font-family: Arial, Helvetica; line-height:16px;">
						<table width="100%" border="0" cellspacing="0" cellpadding="0">
                          <tr>
                            <td width="6%" valign="top"  style="8px 0 8px 0; color:#004fc8;">&bull;</td>
                            <td width="94%" valign="top" style="8px 0 8px 0; font-family: Arial, Helvetica; font-size:12px;line-height:16px;">The certified electronic prescribing computer application must also be registered with the New York State Department of Health (DOH) and Bureau of Narcotic Enforcement (BNE)</td>
                          </tr>
                            <tr>
                            <td width="6%" valign="top"  style="padding:6px 0 6px 0; color:#004fc8; font-size:16px;">&bull;</td>
                            <td width="94%" valign="top" style="padding:6px 0 6px 0; font-family: Arial, Helvetica; font-size:12px; line-height:16px;">For more information regarding the Department of Health’s registration process  for certified electronic prescribing computer applications, please visit <a href="www.nyhealth.gov/professionals/narcotic">www.nyhealth.gov/professionals/narcotic</a>. After March 27, 2015, practitioners are permitted to use the Official New York State Prescription forms in the event of a technological failure or power outage</td>
                            </tr>
                            
                  <tr>
                        <td colspan="2" style="font-family: Arial, Helvetica; font-size:12px; line-height:16px;padding-bottom:8px;">We understand that the new mandate to issue electronic prescriptions for controlled substances may require some adjustment to your current practices, but hope that you will find it to be a useful system for providing adequate pain management options for appropriate patients while minimizing the risks of abuse and diversion for controlled substances.</td>
                      </tr>
                      
						  
				  <tr>
															   <td colspan="2" valign="top" style="padding-bottom:8px;"><span style="font-family: Arial, Helvetica;font-size:12px;line-height: 16px;">
															   <p>Should you have further questions, please contact the Bureau of Narcotic Enforcement at <a href="mailto:narcotic@health.state.ny.us">narcotic@health.state.ny.us</a> or call at 1-866-811-7957, Option 1. </p>
                                                               	
                                                               </span></td></tr>
															   <tr>
															   <td colspan="2" valign="top" style="padding-bottom:8px;">
															   <p><span style="font-family: Arial, Helvetica;font-size:12px;line-height: 16px;">In addition, more information on OxyContin is available at: <a href="http://www.PurdueHCP.com/OxyContin">http://www.PurdueHCP.com/OxyContin</a>.</span></p>
															   
															   </td></tr>
															   
															   <tr>
															   <td colspan="2" valign="top" style="padding-bottom:16px;"><span style="font-family: Arial, Helvetica;font-size:12px;line-height: 16px;">


<div>Please click here to read the<br> <a href="http://www.purduepharma.com/pressroom/news/OxycontinPI.pdf?cid=email_2011rtty" vlink="inherit" style="color:blue; visited:inherit;">Full Prescribing Information</a>, including <br><a href="#" vlink="inherit" style="color:blue; visited:inherit;">Boxed Warning</a>.
</div>
</span></td></tr>




<tr>
															   <td colspan="2" valign="top" style="padding-bottom:8px;"><span style="font-family: Arial, Helvetica;font-size:12px;line-height: 16px;">


<p>Sincerely,</p><br><br> 

Your Purdue Pharma Representative 

</div>
                                                               	
                                                               </span></td></tr>
															   
															   
						  
						</table>
												  
					 </td>
				  </tr>
                  <tr>

                  <td style="padding:0px 0 0 19px; font-family: Arial, Helvetica; font-size:12px; line-height:16px;"><table border="0" cellspacing="0" cellpadding="0">
                             
                            </table></td>
                  </tr>	
                  	
                </table></td>
                <td valign="top"><table border="0" cellspacing="0" cellpadding="0">
                  <tr>
                    <td><table width="100%" border="0" cellspacing="0" cellpadding="0">
                      
                    </table></td>
                  </tr>
                  <tr>
                    <td>
                      <table width="249" align="center" border="0" cellspacing="0" cellpadding="0" style="padding-right:20px; padding-left:20px;">
                      <tr>
                        <td height="7" align="left" valign="bottom" style=" font-size:0px; line-height:1px; padding-top:8px;"><img src="http://image.email.purduehcp.com/lib/fe5f1570756d027b771c/m/2/round-top_4022014.png" width="261" height="7" align="left" border="0"></td>
                      </tr>
                      <tr>
                        <td style="border-left:1px solid #000; border-right:1px solid #000;" valign="top">
                         <table width="93%" border="0" align="center" cellpadding="0" cellspacing="0" valign="top">
                          <tr>
                            <td style="padding:5px 0 10px; font-family: Arial, Helvetica; font-size:12px; line-height:16px; font-weight:bold;">WARNING: ADDICTION, ABUSE and MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; and CYTOCHROME P450 3A4 INTERACTION</td>
                          </tr>
                          <tr>
                            <td style="padding:0 0 10px; font-family: Arial, Helvetica; font-size:12px; line-height:16px;font-weight:bold;"> <u>Addiction, Abuse, and Misuse</u><br>
                                OxyContin<sup style="line-height:0px;">&reg;</sup> exposes patients and other users to the risks of opioid addiction, abuse and misuse, which can lead to overdose and death.  Assess each patient’s risk prior to prescribing OxyContin and monitor all patients regularly for the development of these behaviors or conditions <em>[see Warnings and Precautions (5.1)]</em>.
                            </td>
                          </tr>
                          <tr>
                            <td style="padding:0 0 10px; font-family: Arial, Helvetica; font-size:12px; line-height:16px;font-weight:bold;"> <u>Life-Threatening Respiratory Depression </u><br>
                              Serious, life-threatening, or fatal respiratory depression may occur with use of OxyContin. Monitor for respiratory depression, especially during initiation of OxyContin or following a dose increase.  Instruct patients to swallow OxyContin tablets whole; crushing, chewing, or dissolving OxyContin tablets can cause rapid release and absorption of a potentially fatal dose of oxycodone <em>[see Warnings and Precautions (5.2)]</em>.</td>
                          </tr>
                          <tr>
                            <td style="padding:0 0 5px; font-family: Arial, Helvetica; font-size:12px; line-height:16px;font-weight:bold;"> <u>Accidental Ingestion</u><br>
                              Accidental ingestion of even one dose of OxyContin, especially by children, can result in a fatal overdose of oxycodone <em>[see Warnings and Precautions (5.2)]</em>.</td>
                          </tr>
                          <tr>
																	<td style="padding-bottom:0px; padding-top:0">
																		<div style="font-family:Arial, Helvetica, sans-serif; font-size:12px; line-height:16px; text-decoration:underline; font-weight:bold; color:#000000">
																			Neonatal Opioid Withdrawal Syndrome
																		</div>
																	</td>
																</tr>
																<tr>
																	<td style="padding-bottom:5px; padding-top:0">
																		<div style="font-family:Arial, Helvetica, sans-serif; font-size:12px; line-height:16px; font-weight:bold; color:#000000">
																		Prolonged use of OxyContin during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. If opioid use is required for a prolonged period in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available <em>[see Warnings and Precautions (5.3)]</em>.</div>
																	</td>
																</tr>
                                                                <tr>
																	<td style="padding-bottom:0px; padding-top:0">
																		<div style="font-family:Arial, Helvetica, sans-serif; font-size:12px; line-height:16px; text-decoration:underline; font-weight:bold; color:#000000">
																			Cytochrome P450 3A4 Interaction
																		</div>
																	</td>
																</tr>
																<tr>
																	<td style="padding-bottom:0px; padding-top:0">
																		<div style="font-family:Arial, Helvetica, sans-serif; font-size:12px; line-height:16px; font-weight:bold; color:#000000">
																		The concomitant use of OxyContin with all cytochrome P450 3A4 inhibitors may result in an increase in oxycodone plasma concentrations, which could increase or prolong adverse drug effects and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in oxycodone plasma concentration. Monitor patients receiving OxyContin and any CYP3A4 inhibitor or inducer <em>[see Warnings and Precautions (5.14) and Clinical Pharmacology (12.3)]</em>.</div>
																	</td>
																</tr>
                        </table></td>
                      </tr>
                      <tr>
                        <td height="10" align="left" valign="top" style=" font-size:0px; line-height:1px; padding-bottom:20px;"><img src="http://image.email.purduehcp.com/lib/fe5f1570756d027b771c/m/2/round-bot_4022014.png" width="261" align="left" height="10" border="0"></td>
                      </tr>
                    </table></td>
                  </tr>
                  <tr>
                    <td><table width="261" align="center" border="0" cellspacing="0" cellpadding="0">
                      
                    </table></td>
                  </tr>
                </table></td>
              </tr>
            </table></td>
          </tr>
 
          <tr>
            <td width='600px' align="left">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td style="padding:0 19px;"><table border="0" cellspacing="0" cellpadding="0">
                      <tr>
                        <td width='600px;'><table border="0" cellspacing="0" cellpadding="0"><tr>
                            <td><table border="0" cellspacing="0" cellpadding="0">

                           
                         
                      
                      
                      
					      
						</table>
					
                      <tr>
                        <td></td>
                      </tr>
                      
                     
                      
                      
                      
                      
                      		
                      
                    </table></td>
                  </tr>
                </table>
            </td>
          </tr>
          </table>
          <tr>
            <td bgcolor="#e6e7e8" style="padding:12px 0;"><table width="93%" border="0" align="center" cellpadding="0" cellspacing="0">
              <tr>
                <td width="21%"><table width="100%" border="0" cellspacing="0" cellpadding="0">
                  <tr>
                    <td><a href="https://www.purduehcp.com/hcpportal/f?p=201202:REG:0::::c,s,utm_source,utm_medium,utm_content,utm_campaign,P1000_FIRST_NAME,P1000_LAST_NAME,P1000_NPI_NUMBER,P1000_EMail,P1000_ZIP_CODE:exp_scripts,default,oxy_email,email,oxy_logo_footer,exp_scripts,%%=PROPERCASE(First_Name)=%%,%%=PROPERCASE(Last_Name)=%%,%%NPI_NUMBER%%,%%EMAIL ADDRESS%%,%%ZIPCODE%%"><img src="images/oxy_footer.png" width="101" height="21" alt="oxyconting logo" border="0"></a></td>
                  </tr>
                  <tr>
                    <td style="padding-top:12px;"><a href="http://www.purduepharma.com?utm_source=oxy_email&utm_medium=email&utm_content=purdue_logo_footer&utm_campaign=exp_scripts"><img src="images/footer_logos-2-201404.png" width="90" height="44" alt="Purdue" border="0"></a></td>
                  </tr>
                </table></td>
                <td style="font-family:Helvetica,Arial;font-size:10px; line-height:12px;" width="30%;">&copy;2014 Purdue Pharma L.P. <br>One Stamford Forum<br>201 Tresser Boulevard, <br>Stamford, CT 06901-3431<br>
                A8959-O-E&nbsp;&nbsp;&nbsp;&nbsp;<span>8/14</span></td>
                    <td align="center" style="padding-top:3px; padding-bottom:0px;padding-right:3px;">
                    
                        <table border="0" cellpadding="0" cellspacing="0" align="center" height="70">
                            
                          <tr>
                            
                            <td align="center" valign="bottom" style="padding-bottom:10px;">
                          <img src="images/Twitter_logo_blue.png" width="125" height="15" alt="follow@PurduePharma Twitter"></td>
                          
                          </tr>
                         
                        </table>
                    </td>
                  <td width="16%" style="font-size:10px;">
                    <table border="0" cellpadding="0" cellspacing="0" align="top" width="100%">
                        <tr><td style="padding-bottom:3px;"><a href="file:///Macintosh HD/Users/jasonsanchez/Desktop/jobs/OXYCONTIN/A8877-SCS-E/originals/A8877-SCS-E/%%Subscription_Center_URL%%" style="text-decoration:none; color:#040400;"><span style="color:#040400 !important;font-family:Helvetica,Arial;font-size:10px;">Unsubscribe</span></a><br></td></tr>
                        <tr><td style="padding-bottom:3px;"><a href="https://www.purduehcp.com/hcpportal/f?p=HCP:LEGAL:0::::c,utm_source,utm_medium,utm_content,utm_campaign:exp_scripts,oxy_email,email,privacy,exp_scripts#Privacy" style="text-decoration:none; color:#040400"><span style="color:#040400 !important;font-family:Helvetica,Arial;font-size:10px;">Privacy Policy</span></a></td></tr>
                        <tr><td style="padding-bottom:3px;"><a href="https://www.purduehcp.com/hcpportal/f?p=201201:LEGAL:0::::c,utm_source,utm_medium,utm_content,utm_campaign:exp_scripts,oxy_email,email,legal,exp_scripts" style="text-decoration:none; color:#040400"><span style="color:#040400 !important;font-family:Helvetica,Arial;font-size:10px;">Legal Notice</span></a></td></tr>
                        <tr><td><a href="https://www.purduehcp.com/hcpportal/f?p=201201:CONTACT:0::::c,utm_source,utm_medium,utm_content,utm_campaign:exp_scripts,oxy_email,email,contact_us_footer,exp_scripts" style="text-decoration:none; color:#040400;"><span style="color:#040400 !important;font-family:Helvetica,Arial;font-size:10px;">Contact Us</span></a></td></tr>
                    </table>    
                  </td>                
              </tr>
            </table></td>
          </tr>
        </table>
    </td>
  </tr>
</table>

</body>
</html>
